EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Potential of Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Natural Nanocarriers: Concise Review

Florian Draguet, Cyril Bouland iD, Nathan Dubois, Dominique Bron, Nathalie Meuleman iD, Basile Stamatopoulos, Laurence Lagneaux

Pharmaceutics · 07.02.2023 · 15 (2) · 558

DOI: 10.3390/pharmaceutics15020558 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 07.02.2023. Verfasst von Florian Draguet und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical Cell Therapy (LCCT), Jules Bordet Institute, Université Libre de Bruxelles (ULB), 90 Rue Meylemeersch, 1070 Brussels, Belgium. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fonds National de la Recherche Scientifique (FNRS)/Télévie, Association Jules Bordet, Fonds Lambeau-Marteaux.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intercellular communication, through direct and indirect cell contact, is mandatory in multicellular organisms. These last years, the microenvironment, and in particular, transfer by extracellular vesicles (EVs), has emerged as a new communication mechanism. Different biological fluids and cell types are common sources of EVs. EVs play different roles, acting as signalosomes, biomarkers, and therapeutic agents. As therapeutic agents, MSC-derived EVs display numerous advantages: they are biocompatible, non-immunogenic, and stable in circulation, and they are able to cross biological barriers. Furthermore, EVs have a great potential for drug delivery. Different EV isolation protocols and loading methods have been tested and compared. Published and ongoing clinical trials, and numerous preclinical studies indicate that EVs are safe and well tolerated. Moreover, the latest studies suggest their applications as nanocarriers. The current review will describe the potential for MSC-derived EVs as drug delivery systems (DDS) in disease treatment, and their advantages. Thereafter, we will outline the different EV isolation methods and loading techniques, and analyze relevant preclinical studies. Finally, we will describe ongoing and published clinical studies. These elements will outline the benefits of MSC-derived EV DDS over several aspects.

Schlagwörter

Stichwörter der Autor:innen

diseasesdrug delivery system (DDS)exosomesextracellular vesicles (EVs)mesenchymal stromal cells (MSCs)

Autor:innen und Institutionen

  • Laboratory of Clinical Cell Therapy (LCCT), Jules Bordet Institute, Université Libre de Bruxelles (ULB), 90 Rue Meylemeersch, 1070 Brussels, Belgium.
  • Department of Stomatology and Maxillofacial Surgery, Saint-Pierre Hospital, 322 Rue Haute, 1000 Brussels, Belgium.
  • Department of Maxillofacial and Reconstructive Surgery, Grand Hôpital de Charleroi, 3 Grand'Rue, 6000 Charleroi, Belgium.
  • Department of Haematology, Jules Bordet Institute, Université Libre de Bruxelles (ULB), 90 Rue Meylemeersch, 1070 Brussels, Belgium.
  • Medicine Faculty, Université Libre de Bruxelles (ULB), Route de Lennik 808, 1070 Brussels, Belgium.

ORCID-Profile: Cyril Bouland, Nathalie Meuleman

Förderung

  • Fonds National de la Recherche Scientifique (FNRS)/Télévie
  • Association Jules Bordet
  • Fonds Lambeau-Marteaux

Zitieren

APA

Draguet, F., Bouland, C., Dubois, N., Bron, D., Meuleman, N., Stamatopoulos, B., & Lagneaux, L. (2023). Potential of Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Natural Nanocarriers: Concise Review. Pharmaceutics, 15(2), 558. https://doi.org/10.3390/pharmaceutics15020558

Vancouver

Draguet F, Bouland C, Dubois N, Bron D, Meuleman N, Stamatopoulos B, et al. Potential of Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Natural Nanocarriers: Concise Review. Pharmaceutics. 2023;15(2):558. doi:10.3390/pharmaceutics15020558

BibTeX
@article{Draguet2023,
  author = {Draguet, Florian and Bouland, Cyril and Dubois, Nathan and Bron, Dominique and Meuleman, Nathalie and Stamatopoulos, Basile and Lagneaux, Laurence},
  title = {Potential of Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Natural Nanocarriers: Concise Review},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {2},
  pages = {558},
  doi = {10.3390/pharmaceutics15020558}
}
Kostenlos starten →